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Summary
Tumor metastases within the sellar region are un-
common, accounting for up to 5% of all malignant
lesions, and they can mimic pituitary tumor. These
metastases are usually observed in older patients,
with advanced and generalized neoplastic disease,
but also can be the first manifestation of the can-
cer. Possible hormonal disturbances are diabetes
insipidus, hypopituitarism, isolated hormone defi-
ciency and mild hyperprolactinemia. Mass effects,
visual field defects, and headaches occur, too. The
most common origin of the pituitary metastases
are breast and lung cancer, then colon, prostate,
pancreas, thyroid, hematologic disorders and oth-
er neoplasms. The treatment options include neu-
rosurgical resection, irradiation and chemothera-
py. In some cases transsphenoidal surgery might
be helpful for the proper histological diagnosis.
The prognosis is poor and is related to the re-
sponse to the therapy of primary focus. Cases of
lung tumor metastatic to the pituitary and lym-
phoma infiltrating the hypothalamus will be pre-
sented and discussed.
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Introduction
Tumor metastases within the sellar region are uncom-
mon, accounting for up to 5% of all malignant lesions,
and they can mimic pituitary tumor. Similarly, the au-
topsy studies show their presence in less than 5% (1-
3). These metastases are usually observed in older pa-
tients, with advanced and generalized neoplastic dis-
ease, but also can be the first manifestation of the can-
cer. It is difficult to differentiate the benign pituitary
adenomas from metastatic masses basing only on the
visualization by MRI or CT, (4,5). In many cases the
clinical course and anamnesis are crucial. Metastatic
lesions more often result in the hormonal deficits of
several axes, mild hyperprolactinemia, they cause dia-
betes insipidus due to localization in posterior pituitary.
They can be clinically silent for long time, and diag-
nosed in advanced stage or by autopsy. Symptomatic
metastatic tumors lead to local complications, as optic
chiasm compression or infiltration with vision distur-
bances and loss, optic nerve palsy, osseous destruc-
tion, cavernous sinuses and brain structures involve-
ment with intracranial hypertension. Headache or oph-
thalmoplegia occurrence suggests pituitary metastasis
(1-6).
The most common origin of the pituitary metastases
are breast and lung cancer, then colon, prostate, pan-
creas, thyroid, uterus, bladder, liver, hematologic disor-
ders and other neoplasms (1-8).
The treatment options include neurosurgical resection,
irradiation and chemotherapy. In some cases trans-
sphenoidal surgery might be helpful for the proper his-
tological diagnosis. The prognosis is poor and is relat-
ed to the response to the therapy of primary focus (5-
10).
Cases of lung tumor metastatic to the pituitary (9) and
lymphoma infiltrating the hypothalamus with secondary
hypopituitarism (10) are presented.
Case 1
67-ys man with prostatic cancer history, suffering from
fatigue, weakness, cold feeling, blurred vision was sub-
mitted to the endocrinologist. Head CT revealed large
sellar mass, 3.3 x 2.1 x 1.8 cm in diameter, with con-
trast enhancement and partial sellar osteolysis, the
mass compressed optic chiasm and infiltrated the
sphenoid sinus. Pituitary MRI showed large tumor 4.0
x 3.4 x 1.8 cm, located intra- and extrasellar, infiltrating
cavernous and sphenoid sinuses, compressing optic
chiasm and third ventricle (Fig. 1). Hypopituitarism was
confirmed and replacement therapy was administered,
and because of progressing vision loss the patient was
submitted to neurosurgery. Following the successful
neurosurgery the histology of resected tumor revealed
small cell carcinoma with neuroendocrine granulations.
The diagnosis of metastatic pituitary tumor was estab-
lished, and further diagnostics was continued. Lung
small cell carcinoma with metastases to the liver and
pituitary was diagnosed, and chemotherapy started.
Patient died due to progression of lung carcinoma.
Review
Sellar metastases
6 Bolanowski_-  14/11/13  17:25  Pagina 78
©
 C
IC
 Ed
zio
i I
te
na
zio
na
li
Case 2
In 55-ys man with diffuse malignant lymphoma type B
transient optic chiasm infiltration and visual disturbances
but with persistent hypopituitarism, hyperprolactinemia
and diabetes insipidus occurred. The patient was admin-
istered chemotherapy and radiotherapy. Repeated MRI
and CT scans showed optic chiasm infiltration (Fig. 2),
which disappeared in the course of the chemotherapy
but then recurred, changed its appearance and finally
disappeared again (Fig. 3). In the meantime visual distur-
bances occurred and disappeared during the therapy.
Hypopituitarism due to hypothalamus infiltration, dia-
betes insipidus and hyperprolactinemia were diagnosed
and replacement therapy was administered. The patient
died as a result of systemic complications of the disease.
Although pituitary metastases are rare, their occur-
rence must be taken into consideration in patients with
cancer history, progressive course and aggressive be-
havior of pituitary mass. Sometimes, histological ex-
amination following tumor surgery can indicate the ori-
gin of metastasis and allow to start proper therapy.
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Figure 1 - Coronal contrast-enhanced T1-weighted MR im-
age of expansive large pituitary mass (4.0 x 3.4 x 1.8 cm)
intra- and suprasellar, infiltrating left and right cavernous si-
nus, sphenoid sinus, with optic chiasm and third ventricle
compression.
Figure 2 - Coronal contrast-enhanced T1-weighted MR im-
age shows optic chiasm infiltration 1.7 x 1.3 cm. Pituitary
gland is normal.
Figure 3 - Coronal contrast-enhanced T1-weighted MR im-
age shows no pathological changes within suprasellar re-
gion. Optic chiasm is still normal; regression of the lesion
previously seen.
6 Bolanowski_-  14/11/13  17:25  Pagina 79
©
 C
IC
 Ed
izi
on
i I
nt
er
na
zio
na
li
